Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Germinoma × Bleomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hodgkin Disease 47 Lymphoma 41 HIV Infections 11 Acquired Immunodeficiency Syndrome 11 Lymphoma, Large B-Cell, Diffuse 9 Testicular Neoplasms 8 Teratoma 8 Lymphoma, Non-Hodgkin 8 Sarcoma, Kaposi 7 Neoplasms 6 Head and Neck Neoplasms 6 Lymphoma, Large-Cell, Immunoblastic 5 Lymphoma, Follicular 5 Endodermal Sinus Tumor 5 Testicular Germ Cell Tumor 4 Recurrence 4 Ovarian Germ Cell Cancer 4 Neoplasms, Germ Cell and Embryonal 4 Neoplasm Metastasis 4 Carcinoma, Squamous Cell 4 Carcinoma, Embryonal 4 Vulvar Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Seminoma 3 Ovarian Neoplasms 3 Teratoma, Testicular 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Dendritic Cell Sarcoma, Interdigitating 2 Central Nervous System Neoplasms 2 Cardiotoxicity 2

Interventions

Etoposide 3 Carboplatin 3 tremelimumab 1 etoposide phosphate 1 durvalumab 1 Surgical Procedures, Operative 1 Spinal Puncture 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Photochemotherapy 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Ifosfamide 1 Granulocyte Colony-Stimulating Factor 1 Drug Therapy 1 Dihematoporphyrin Ether 1 Cyclophosphamide 1 Cisplatin 1 Bleomycin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02782754 2016-05-25

Chemotherapy Plus Reduced Radiotherapy in Intracranial Germinoma

Samsung Medical Center

Phase 2 Unknown

Germinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡